Factors affecting efficacy in patients with genotype 2 chronic hepatitis C treated by pegylated interferon alpha-2b and ribavirin: reducing drug doses has no impact on rapid and sustained virological responses

2010 ◽  
Vol 17 (5) ◽  
pp. 336-344 ◽  
Author(s):  
Y. Inoue ◽  
N. Hiramatsu ◽  
T. Oze ◽  
T. Yakushijin ◽  
K. Mochizuki ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Factors Affecting ◽  
Interferon Alpha 2B ◽  
Genotype 2 ◽  
Drug Doses

Pegylated interferon alpha 2b for chronic hepatitis C

2009 ◽  
Author(s):  
Tahany Awad ◽  
Kristian Thorlund ◽  
Goran Hauser ◽  
Mahasen Mabrouk ◽  
Davor Stimac ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B

Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients

AIDS ◽  
2004 ◽  
Vol 18 (1) ◽  
pp. 131
Author(s):  
Steven Callens ◽  
Emmanuel Bottieau ◽  
Peter Michielsen ◽  
Robert Colebunders
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Alpha ◽  
Pegylated Interferon ◽  
Pegylated Interferon Alpha ◽  
Interferon Alpha 2B
Sign in / Sign up

Export Citation Format

Share Document